RXO INC (RXO) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:RXO • US74982T1034

15.95 USD
-0.95 (-5.62%)
Last: Feb 9, 2026, 11:13 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall RXO gets a fundamental rating of 3 out of 10. We evaluated RXO against 42 industry peers in the Ground Transportation industry. RXO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, RXO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • RXO had negative earnings in the past year.
  • In the past year RXO had a positive cash flow from operations.
  • In multiple years RXO reported negative net income over the last 5 years.
  • Of the past 5 years RXO 4 years had a positive operating cash flow.
RXO Yearly Net Income VS EBIT VS OCF VS FCFRXO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M 300M

1.2 Ratios

  • RXO has a worse Return On Assets (-3.05%) than 66.67% of its industry peers.
  • The Return On Equity of RXO (-6.49%) is worse than 64.29% of its industry peers.
Industry RankSector Rank
ROA -3.05%
ROE -6.49%
ROIC N/A
ROA(3y)-3.78%
ROA(5y)0.09%
ROE(3y)-7.94%
ROE(5y)1.18%
ROIC(3y)N/A
ROIC(5y)N/A
RXO Yearly ROA, ROE, ROICRXO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • Looking at the Gross Margin, with a value of 16.39%, RXO is doing worse than 71.43% of the companies in the same industry.
  • RXO's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for RXO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.99%
GM growth 5Y-2.2%
RXO Yearly Profit, Operating, Gross MarginsRXO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • RXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RXO has been increased compared to 1 year ago.
  • Compared to 5 years ago, RXO has more shares outstanding
  • RXO has a worse debt/assets ratio than last year.
RXO Yearly Shares OutstandingRXO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M
RXO Yearly Total Debt VS Total AssetsRXO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.64 indicates that RXO is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • RXO has a Altman-Z score (2.64) which is in line with its industry peers.
  • RXO has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.25, RXO is doing good in the industry, outperforming 61.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 2.64
ROIC/WACCN/A
WACC10.15%
RXO Yearly LT Debt VS Equity VS FCFRXO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that RXO should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.27, RXO is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • A Quick Ratio of 1.27 indicates that RXO should not have too much problems paying its short term obligations.
  • RXO's Quick ratio of 1.27 is in line compared to the rest of the industry. RXO outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
RXO Yearly Current Assets VS Current LiabilitesRXO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • RXO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -145.45%.
  • The Revenue has grown by 26.20% in the past year. This is a very strong growth!
  • Measured over the past years, RXO shows a quite strong growth in Revenue. The Revenue has been growing by 11.33% on average per year.
EPS 1Y (TTM)-145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y6.18%
Revenue growth 5Y11.33%
Sales Q2Q%-11.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 244.37% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, RXO will show a quite strong growth in Revenue. The Revenue will grow by 9.55% on average per year.
EPS Next Y330.28%
EPS Next 2Y244.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.84%
Revenue Next 2Y4.76%
Revenue Next 3Y15.95%
Revenue Next 5Y9.55%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
RXO Yearly Revenue VS EstimatesRXO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
RXO Yearly EPS VS EstimatesRXO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • RXO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 138.53, the valuation of RXO can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of RXO indicates a slightly more expensive valuation: RXO is more expensive than 64.29% of the companies listed in the same industry.
  • RXO is valuated expensively when we compare the Price/Forward Earnings ratio to 27.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 138.53
RXO Price Earnings VS Forward Price EarningsRXO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 -200 -300

4.2 Price Multiples

  • RXO's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. RXO is more expensive than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29
RXO Per share dataRXO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • RXO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • RXO's earnings are expected to grow with 244.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y244.37%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • RXO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RXO INC

NYSE:RXO (2/9/2026, 11:13:10 AM)

15.95

-0.95 (-5.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)02-06
Earnings (Next)05-05
Inst Owners110.21%
Inst Owner Change-0.92%
Ins Owners0.65%
Ins Owner Change0.23%
Market Cap2.62B
Revenue(TTM)5.74B
Net Income(TTM)-100.00M
Analysts66.92
Price Target15.77 (-1.13%)
Short Float %6.03%
Short Ratio4.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-82.55%
Min EPS beat(2)-92.79%
Max EPS beat(2)-72.3%
EPS beat(4)1
Avg EPS beat(4)-30.98%
Min EPS beat(4)-92.79%
Max EPS beat(4)101.04%
EPS beat(8)5
Avg EPS beat(8)-7.73%
EPS beat(12)8
Avg EPS beat(12)37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2%
Min Revenue beat(2)-2.2%
Max Revenue beat(2)-1.8%
Revenue beat(4)0
Avg Revenue beat(4)-2.86%
Min Revenue beat(4)-5.04%
Max Revenue beat(4)-1.8%
Revenue beat(8)1
Avg Revenue beat(8)-1.36%
Revenue beat(12)2
Avg Revenue beat(12)-2.06%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.36%
PT rev (3m)-7.42%
EPS NQ rev (1m)-43.8%
EPS NQ rev (3m)-160.42%
EPS NY rev (1m)-112.75%
EPS NY rev (3m)-101.24%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-3.84%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 138.53
P/S 0.46
P/FCF N/A
P/OCF 51.32
P/B 1.7
P/tB N/A
EV/EBITDA 29
EPS(TTM)-0.05
EYN/A
EPS(NY)0.12
Fwd EY0.72%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.31
OCFY1.95%
SpS34.99
BVpS9.39
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.05%
ROE -6.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.39%
FCFM N/A
ROA(3y)-3.78%
ROA(5y)0.09%
ROE(3y)-7.94%
ROE(5y)1.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.99%
GM growth 5Y-2.2%
F-Score5
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA 3.55
Cap/Depr 50.86%
Cap/Sales 1.03%
Interest Coverage N/A
Cash Conversion 46.79%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 2.64
F-Score5
WACC10.15%
ROIC/WACCN/A
Cap/Depr(3y)66.04%
Cap/Depr(5y)62.51%
Cap/Sales(3y)1.22%
Cap/Sales(5y)1.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y330.28%
EPS Next 2Y244.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.2%
Revenue growth 3Y6.18%
Revenue growth 5Y11.33%
Sales Q2Q%-11.88%
Revenue Next Year2.84%
Revenue Next 2Y4.76%
Revenue Next 3Y15.95%
Revenue Next 5Y9.55%
EBIT growth 1Y-123.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.22%
EBIT Next 3Y117.18%
EBIT Next 5Y60.11%
FCF growth 1Y85.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y525%
OCF growth 3Y-45.21%
OCF growth 5Y15.33%

RXO INC / RXO FAQ

What is the fundamental rating for RXO stock?

ChartMill assigns a fundamental rating of 3 / 10 to RXO.


What is the valuation status for RXO stock?

ChartMill assigns a valuation rating of 2 / 10 to RXO INC (RXO). This can be considered as Overvalued.


What is the profitability of RXO stock?

RXO INC (RXO) has a profitability rating of 1 / 10.


What is the expected EPS growth for RXO INC (RXO) stock?

The Earnings per Share (EPS) of RXO INC (RXO) is expected to grow by 330.28% in the next year.